JAK2 and head and neck squamous cell carcinoma: To analyze whether they are upstream pathways of JAK2/STAT3 in SCCHN, PCI-4B and PCI-37B cells were pretreated with PI3K inhibitor (LY294002), Src inhibitor (PP2), and pyk2 inhibitor (A9).